StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) stock

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$12.90−0.34 (-2.57%)

Close on Nov 18, 2026Market cap $1.95BP/E –Yield –

Biohaven cash

Cash and short-term investments held at the end of each period.

Biohaven's cash was $161.13M at Sep 30, 2026. For fiscal 2025 it was $319.14M, down 34.8% from the year before. The highest annual figure on record is $503.07M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$319.14M-34.8%
FY2024Dec 31, 2024$489.40M+28.2%
FY2023Dec 31, 2023$381.82M-24.1%
FY2022Dec 31, 2022$503.07M+552.9%
FY2021Dec 31, 2021$77.06M-7.7%
FY2020Dec 31, 2020$83.51M+742.0%
FY2019Dec 31, 2019$9.92M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$161.13M-38.1%
Q2 FY2026Jun 30, 2026$267.87M-33.9%
Q1 FY2026Mar 31, 2026$347.82M+7.8%
Q4 FY2025Dec 31, 2025$319.14M-34.8%
Q3 FY2025Sep 30, 2025$260.22M-31.3%
Q2 FY2025Jun 30, 2025$404.98M-7.3%
Q1 FY2025Mar 31, 2025$322.75M+13.9%
Q4 FY2024Dec 31, 2024$489.40M+28.2%
Q3 FY2024Sep 30, 2024$378.82M+57.4%
Q2 FY2024Jun 30, 2024$436.95M+30.4%
Q1 FY2024Mar 31, 2024$283.42M-27.0%
Q4 FY2023Dec 31, 2023$381.82M-24.1%
Q3 FY2023Sep 30, 2023$240.60M+374.8%
Q2 FY2023Jun 30, 2023$335.12M+1343.9%
Q1 FY2023Mar 31, 2023$388.03M+863.9%
Q4 FY2022Dec 31, 2022$503.07M+552.9%
Q3 FY2022Sep 30, 2022$50.67M-86.0%
Q2 FY2022Jun 30, 2022$23.21M-72.2%
Q1 FY2022Mar 31, 2022$40.26M+305.9%
Q4 FY2021Dec 31, 2021$77.06M–
Q3 FY2021Sep 30, 2021$361.70M–
Q4 FY2020Dec 31, 2020$83.51M–
Q4 FY2019Dec 31, 2019$9.92M–

More Biohaven figures

See a number that looks wrong?